EW
EW
US28176E1082
Edwards Lifesciences Corporatio
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
49.06B EUR
52.14B EUR
46.21B EUR
49.5B EUR
Enterprise Value
45.11B EUR
52.14B EUR
44.46B EUR
47.27B EUR
Valuation Multiples
Trailing P/E
50.72x
68.34x
42.15x
46.12x
Forward P/E
25.23x
--
--
--
Price to Sales
7.53x
10.93x
7.33x
8.16x
Price to Book
4.63x
--
4.47x
4.79x
EV/Revenue
6.93x
10.93x
7.05x
7.79x
EV/EBITDA
22.59x
30.97x
20.03x
24.06x
Price to FCF (P/FCF)
39.81x
61.44x
42.41x
37.08x
EV/FCF
36.61x
61.44x
40.81x
35.41x
FCF Yield
2.51%
1.63%
2.36%
2.7%
ende